Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Global Times.
Press releases published on April 29, 2025

L’entreprise de biotechnologie britannique Stablepharma Ltd. lance en première mondiale un essai de Phase I ciblé sur un vaccin thermostable contre le tétanos et la diphtérie
LONDRES, 29 avr. 2025 (GLOBE NEWSWIRE) -- Après avoir obtenu l’autorisation de la MHRA, l’autorité britannique de réglementation du marché des dispositifs médicaux, Stablepharma Ltd. entre en essai clinique de Phase I pour son principal candidat, SPVX02, …

DIDWW acquires its own virtual phone numbers in Denmark, the Czech Republic, Spain and Costa Rica
DUBLIN, April 29, 2025 (GLOBE NEWSWIRE) -- DIDWW, a global telecom provider of fully compliant two-way SIP trunking services to operators and businesses, has further expanded the coverage of its virtual phone numbers. Denmark, the Czech Republic, Spain, …

Vixio Launches Vixio Workspace: A Transformative Regulatory Management Tool
London, April 29, 2025 (GLOBE NEWSWIRE) -- Vixio, a leading provider of regulatory intelligence solutions, is excited to announce the launch of Vixio Workspace, a new regulatory management tool designed by compliance professionals, for compliance …

Human Magic Accelerates Global Growth with Agency Acquisition in Australia
LIVERPOOL, United Kingdom, April 29, 2025 (GLOBE NEWSWIRE) -- Human Magic, the global employer brand agency behind creative strategies for brands like Nike, Microsoft, Apple, LinkedIn, and AstraZeneca, today announces its expansion into the Australian …

Microbiotica reveals novel mechanisms showing how the microbiome can improve immunotherapy response based on MB097, a clinical-stage drug candidate being evaluated in combination with KEYTRUDA® (pembrolizumab) in patients with advanced melanoma
CAMBRIDGE, United Kingdom, April 29, 2025 (GLOBE NEWSWIRE) -- Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), has presented new data on the mechanism …

DEBRA Research Announces Impact Investment into Nova Anchora to Advance Protein Therapy for Epidermolysis Bullosa
Additional investors include global investment firm Viking Global Investors, charity foundation CureEB, the Epidermolysis Bullosa Medical Research Foundation (EBMRF), and Stanford University. The financing will enable Nova Anchora to advance its lead …

deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection
deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection Round co-led by Columbus Venture Partners, Panakès Partners and Mérieux Equity Partners Barcelona, Spain – 29 …

Forbion leads €18M Series A Financing in Textile Recycling Technology company EEDEN
NAARDEN, The Netherlands, April 29, 2025 (GLOBE NEWSWIRE) -- Forbion, a leading venture capital firm with deep biotech expertise in Europe announces it has led the €18 million Series A financing round through its BioEconomy fund of German tech startup …

Open Dialogue 'Future of the World. New Platform for Global Growth' Launches at Russia National Centre
MOSCOW, RUSSIA, April 29, 2025 (GLOBE NEWSWIRE) -- More than one hundred representatives from 48 countries have gathered in Moscow at the National Centre "Russia" for the Open Dialogue 'Future of the World. New Platform for Global Growth'. This first-of- …

EXEL Industries: Second quarter 2024–2025 sales down 3.8%
Q2 2024–2025 revenue: -3.8% Businesses proved to be resilient in an uncertain economic context Q2 sales (January 2025–March 2025)) 2023–2024 2024–2025 Change (reported) Change (LFL*) Reported Reported €m % €m % AGRICULTURAL SPRAYING 157.4 132.7 -24.7 -15 …

EXEL Industries : Chiffre d’affaires 2e trimestre 2024–2025 -3,8 %
Chiffre d’affaires 2e trimestre 2024–2025 : - 3,8 % Bonne résistance des activités dans un contexte économique incertain Chiffre d'affaires T2 (janvier 2025–mars 2025)) 2023–2024 2024–2025 Variation à données publiées Variation à tcpc* Publié Publié …

eeden erhält 18 Mio. € Series-A zur Skalierung seiner bahnbrechenden Textilrecycling-Technologie
Münster, 29.04.2025 - Das Technologie-Start-up eeden, das eine hochinnovative Recyclingtechnologie für Textilien entwickelt hat, gibt den erfolgreichen Abschluss seiner Series-A-Finanzierungsrunde in Höhe von 18 Millionen Euro bekannt. Angeführt wurde die …

eeden Closes €18M Series A Financing to Scale its Breakthrough Textile Recycling Technology
Münster, 29.04.2025 - German tech startup eeden, which has developed a groundbreaking textile recycling technology, announces the completion of its €18 million Series A funding round. The round was led by Forbion, a leading venture capital firm based in …

Progress on share buyback programme
Progress on share buyback programme ING announced today that, as part of our €2.0 billion share buyback programme announced on 31 October 2024, in total 4,609,386 shares were repurchased during the week of 22 April 2025 up to and including 25 April 2025. …

Rexel: First-Quarter 2025 Sales
Q1 2025 sales Same-day sales up +1.4% in Q1 25, back to positive territory Sales growth driven by North America, with improving trends in Europe Active portfolio management with one acquisition and one disposal completed in April Full-year guidance …

Rexel : Ventes du T1 2025
Ventes du premier trimestre 2025 Ventes en hausse de +1,4% au T1 25 à jours constants, de retour en territoire positif Croissance des ventes tirée par l'Amérique du Nord, avec une amélioration des tendances en Europe Gestion active du portefeuille avec une …

Santhera veröffentlicht Einladung zur ordentlichen Generalversammlung
Pratteln, Schweiz, 29. April 2025 - Santhera Pharmaceuticals (SIX: SANN) hat heute die Einladung zur ordentlichen Generalversammlung (GV) veröffentlicht, die am 20. Mai 2025 um 10:00 Uhr MESZ im Haus der Wirtschaft, Hardstrasse 1, 4133 Pratteln, Schweiz, …

Santhera Publishes Agenda for its Annual General Meeting
Pratteln, Switzerland, April 29, 2025 – Santhera Pharmaceuticals (SIX: SANN) today published the invitation to its Annual General Meeting (AGM), which will be held on May 20, 2025, at 10:00 CEST at Haus der Wirtschaft, Hardstrasse 1, 4133 Pratteln, …

BAWAG Group erzielte in Q1 2025 Nettogewinn von 201 Mio. € und RoTCE von 25,8%
BAWAG Group gibt heute ihre Ergebnisse für das erste Quartal 2025 bekannt, mit einem Nettogewinn in Höhe von 201 Mio. €, einem Gewinn je Aktie von 2,54 €, und einem Return on Tangible Common Equity von 25,8%. Das Ergebnis vor Risikokosten belief sich auf …

BAWAG Group publishes Q1 2025 results: Net profit € 201 million and RoTCE 25.8%
Today, BAWAG Group released its results for the first quarter 2025, reporting a net profit of € 201 million, earnings per share of € 2.54, and a RoTCE of 25.8%. Pre-provision profits were at € 336 million and the cost-income ratio at 37%. The first quarter …